|
Name |
Methyl isostearate
|
Molecular Formula | C19H38O2 | |
IUPAC Name* |
methyl 16-methylheptadecanoate
|
|
SMILES |
CC(C)CCCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C19H38O2/c1-18(2)16-14-12-10-8-6-4-5-7-9-11-13-15-17-19(20)21-3/h18H,4-17H2,1-3H3
|
|
InChIKey |
KDQIFKKWPMBNOH-UHFFFAOYSA-N
|
|
Synonyms |
Methyl isostearate; Methyl 16-methylheptadecanoate; 5129-61-3; 68517-10-2; Heptadecanoic acid, 16-methyl-, methyl ester; 16-Methylheptadecanoic acid methyl ester; 16-METHYLHEPTADECANOICACIDMETHYLESTER; 2B9VP4H2JC; EC 614-560-4; Isooctadecanoic acid, methyl ester; Isooctadecanoic acid,methyl ester; Methyl isooctadecanoate; UNII-2B9VP4H2JC; SCHEMBL8601185; DTXSID401027738; ZINC4557074; 16-Methylheptadecanoic acid-methyl ester; FT-0607253; Q63409252
|
|
CAS | 5129-61-3 | |
PubChem CID | 110444 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 298.5 | ALogp: | 8.7 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 21 | QED Weighted: | 0.263 |
Caco-2 Permeability: | -4.751 | MDCK Permeability: | 0.00001340 |
Pgp-inhibitor: | 0.022 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.951 |
30% Bioavailability (F30%): | 0.988 |
Blood-Brain-Barrier Penetration (BBB): | 0.233 | Plasma Protein Binding (PPB): | 97.18% |
Volume Distribution (VD): | 2.235 | Fu: | 1.64% |
CYP1A2-inhibitor: | 0.245 | CYP1A2-substrate: | 0.195 |
CYP2C19-inhibitor: | 0.409 | CYP2C19-substrate: | 0.121 |
CYP2C9-inhibitor: | 0.222 | CYP2C9-substrate: | 0.97 |
CYP2D6-inhibitor: | 0.066 | CYP2D6-substrate: | 0.03 |
CYP3A4-inhibitor: | 0.331 | CYP3A4-substrate: | 0.075 |
Clearance (CL): | 5.19 | Half-life (T1/2): | 0.182 |
hERG Blockers: | 0.177 | Human Hepatotoxicity (H-HT): | 0.031 |
Drug-inuced Liver Injury (DILI): | 0.421 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.014 |
Skin Sensitization: | 0.956 | Carcinogencity: | 0.053 |
Eye Corrosion: | 0.941 | Eye Irritation: | 0.962 |
Respiratory Toxicity: | 0.885 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001160 | 0.949 | D07ILQ | 0.545 | ||||
ENC001181 | 0.908 | D0Z5SM | 0.468 | ||||
ENC000548 | 0.898 | D00FGR | 0.441 | ||||
ENC001519 | 0.847 | D0P1RL | 0.429 | ||||
ENC000271 | 0.794 | D00AOJ | 0.416 | ||||
ENC001142 | 0.769 | D0O1PH | 0.404 | ||||
ENC000496 | 0.758 | D0T9TJ | 0.402 | ||||
ENC000489 | 0.746 | D05ATI | 0.395 | ||||
ENC000560 | 0.746 | D0G2KD | 0.375 | ||||
ENC000316 | 0.735 | D00MLW | 0.362 |